SYDNEY KRANTZ: Open Payments
NPI 1023890019 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$760 in 40 payments from 11 companies in 2025. Trend: 2023 $33 · 2024 $807 · 2025 $760
Food & beverage: $760
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $240 |
| Lilly USA, LLC | 5 | $96 |
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
| Esperion Therapeutics, Inc. | 3 | $60 |
| Exact Sciences Corporation | 3 | $59 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Kowa Pharmaceuticals America, Inc. | 3 | $46 |
| PFIZER INC. | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
Products named: Ozempic, NEXLETOL, The Cologuard Plus Collection Kit, Wegovy, AIRSUPRA, GARDASIL 9, ZORYVE, ZEPBOUND.
Industry payments across FL — which companies pay providers there.
